Patients should be more aware of the dangers and risks that come with their prescription medications. Although they may be approved by the Food and Drug Administration (FDA) they can still cause serious health complications, and when they do they should immediately be reported in order to avoid further health dangers and for the FDA to take necessary actions to protect the consumers. Among the newest prescription lawsuits is Xarelto.

As of April 2015, there are already 400 lawsuits filed against the manufacturer of the drug. Generally used for treatment as a blood thinner for stroke patients who have just undergone hip and knee replacement surgery and for those who have suffered blood clots, Xarelto has not been approved for other uses such as Acute Coronary Syndrome (ACS). Despite the success of Xarelto as a blood thinning drug, the severe side effects should not be disregarded. According to the website of Williams Kherkher, gastrointestinal bleeding, brain hemorrhage, and hemorrhagic stroke can be fatal to patients who use Xarelto because there is no cure or counteracting medication to stop the bleeding.

The number of Xarelto lawsuits filed against Janssen Research and Development was mainly due to the manufacturers’ failure to warn patients of the risks of bleeding by wrongfully representing it. Negligent misrepresentation and breach of warranty are also among the reasons for the rising number of Xarelto lawsuits. What makes Xarelto dangerous is the lack of counteracting drug to help prevent or stop bleeding.

Since patients rely on their medications to cope with certain aspects of their health, taking prescription medications has become a part of life. Products that pose excessive risks or unnecessary dangers to the health of the consumers are reported and sometimes recalled. Since its FDA approval in 2011, Xarelto is yet to be recalled, the manufacturer should still be held accountable for its negligence.